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Hemoglobin Zurich is a hemoglobin anomaly tha t results when one 
amino acid (histidine) is substituted by arginine at position 63 in the beta 
chain of hemoglobin molecules [8 63 His---Argl. When Hemoglobirl Zurich 
individuals are exposed to sulfonamide medication, their hemoglobins 
denature and subsequently form Heinz bodies which attach to the surface of 
the plasma membrane. 
Four Hemoglobin Zurich family members were the subjects of the 
current study. They included a splenectomized female subject, non-
splenectomized female and male subjects, and a non-splenectomized 
femal e member without Hemoglobin Zurich as the control. The results 
collaborate that splenectomy increases the n umber of erythrocytes 
containing Heinz bodies in peripheral blood. The menstrual cycle 
apparently has no statistical affect on the increased ratio of Heinz body-
containing erythrocytes to normal erythrocytes. 
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INTRODUCTION 
Upon the administration of anti-microbial sulfonamides, patients with 
Hemoglobin Zurich (Hb Zurich) exhibit severe erythrocytic hemolysis. The 
abnormal hemoglobin was discovered in Zurich, Switzerland, in 1960 by 
Hitzig et a!. [1]. Subsequently, other cases were reported in Maryland [2) 
and Japan [3]. Hb Zurich is the result of a specific genetic mutation [863 
His--Arg) in which there is a single amino acid substitution in the beta 
chain of the hemoglobin molecule [4). The side chain of the distal arginine 
attaches itself to the propionate of the heme, leaving the heme pocket open, 
allowing sulfona~ides access to the iron [5) . Denatured hemoglobins bind 
tightly to the erythrocytic membrane, often forming dense aggregates on 
the inner membrane surface termed Heinz bodies. Hemoglobin is 
denatured by being oxidized initially to methemoglobi . Minor structural 
rearrangements can lead to formation of a reversible hemichrome which 
under appropriate conditions can revert back to methemoglobin. Otherwise, 
the r eversible hemichromes denature further to form irreversible 
hemichro es which eventually aggregate to form Heinz bodies. The rate 
of hemoglobin denaturation in Hemoglobin Z rich patients is greater than 
in normal individuals [6]. 
The abnormal hemoglobin employed in the current study was detected 
initially by Dr. Alfred Kraus, University of Tennessee Medical School, in 
1965. Since Hemoglobin Zurich in this family has not been previously 
reported in the literature, a summary of the original case report follows. A 
female patient, approximately two months pregnant, developed a urinary 
tract infection during the latter part of January, 1965, and was treated with 
sulfadyne, eight tablets daily, four days continuously. On day four, she 
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became jaundiced and then developed aching in the neck, nausea, spots in 
front of her eyes, and dark urine. On admission to the Baptist Memorial 
Hospital, Memphis, Tennessee, she was found to have a temperature :>f 
lOO°F and continued with the low grade fever for the next several days. 
Anemia and autohemolysis tests were performed. The urine was 
essentially normal. Initial blood analysis resulted in the following: 
total protein 6.3; 
albumin 4.3 ; 
alka line phosphatase, 3.0 King-Armscrong units; 
serine glutamine pyruvate transaminase, 21; 
cholesterol , 174; 
bilirubin total, 6.2 mg%, direct, 0.2 mg%; 
direct Coombs test, negative. 
Because of these unusual findings, the following additional laboratory 
determinations were performed: 
rapid screening for glucose-6 phosphate dehydrogenase deficiency, 
normal; 
lactic acid dehydrogenase electrophoresis. normal; 
two varieties of hemoglobin: one with the mobility of hemoglobin A and 
the other with the mobility of hemoglobin S; 
sickle cell preparation, negative; 
fetal hemoglobin, 3.5%. 
Heinz body studies were initiated three days after the blood had been 
obtained from the patient. The blood was exposed to acetyl phenylhydrazine 
and stained with brilliant cresyl blue. Numerous Heinz bodies were present 
in each cell. Peptide mapping and amino acid analysis of the hemoglobin 
resulted in its identification as Hemoglobin Zurich. Because of severe 
3 
anemia occurring in the second month of pregnancy, the patient was given 
several units of packed erythrocytes, and a splenectomy was performed. 
The spleen was found to be enlal"ged and estimated to be about three times 
normal size. The pathologist reported that the spleen weighed 150 grams. 
Microscopic examination showed no specific abnormalities other than 
some nucleated red cells in the splenic pulp. The rest of the family 
members were screened for the abnormal hemoglobin with the resul t s 
shown 10 the pedigree chart, Figure l. 
Heinz bodies were first described in 1890 by Robert Heinz [7, 8]. They are 
insoluble, oxidatively denatured hemoglobin which reflects the presence of 
a metabolic derangement or abnormality in the primary structure of 
hemoglobin [9]. The principles of their formation and increased hemolysis 
are: 1) deficiency in one of the reducing systems of blood, ~ glucose-6-
phosphate dehydrogenase deficiency; 2) presence of an unstable 
hemoglobin, such as Hemoglobin Shepherk's Bush, Hemoglobin Gun Hill, 
Hemoglobin Philly and Hemoglobin Zurich; and 3) exposure to certain 
chemicals and drugs , .e..JL. sulfonamide medication inducing hemolytic 
anemia in people who have a reducing system deficiency and no unstable 
hemuglobin [10]. Since the spleen removes aged or defective blood cells and 
platelets from the blood llnd acts as a blood filter, the rate of removal of 
erythrocytes containing Heinz bodies after a splenectomy will be slower [11]. 
A study in which erythrocytes containing Reinz bodies were injected into 
premature infants and adults with and without a splenectomy reported 
that the rate of removal was decreased after splenectomy [12]. 
The purpose of this time-course study is to compare the ratio of intra-
erythrocytic Heinz bodies of Hemoglobm Zurich members of the same 
family utilizing two parameters: splenectomized and non-splenectomized 
· .. 
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individuals. The course of the study was five weeks. 
(S) (e) 
(F) (M) 
Key: Hemoglobin Zurich Individuals 
Figure 1. Pedigree chart of the Hemoglobin Zurich family. Abbreviations: 
S= Splenectomized female Hemoglobin Zurich subject; F= Non-
splenectomized female Hemoglobin Zurich subject; M= Non-
splenectomized male Hemoglobin Zurich subject; C= Female 
control. 
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MATERIALS AND METHODS 
Fresh Hemoglobin Zurich blood samples were acquired from the 
menostasic female subject (S), who was splenectomized in 1965; a non-
splenectomized Hemoglobin Zurich female, (F), who is non-menostasic and 
the daughter of the subject; a non-Hemoglobin Zurich, non-menostasic 
female, (C), the sister of S, who was one of the control subjects in tltis study; 
and a nephew of the individuals S and C, who was the second control, 
(Figure 1). Five to 10 ml of blood were drawn on Monday from each per~on 
for five continuous weeks by one of the following health facilities: The 
Medical Center at Bowling Green, Bowling Green Medical Clinic and the 
Student Health Clinic at Western Kentucky University, Bowling Green, 
Kentucky. EDTA was the anticoagulant. 
The erythrocytes were stained with crystal violet obtained from 
Matheson Coleman and Bell Division, Norwood, Ohio. The blood was 
examined immediately after drawn, no more than four hours later, with 
one exception; the male subject's blood drawn on the fourth week was 
exantined two weeks later. 
Heinz bodies were stained with crystal violet according to the method of 
Beutler [12] with the following modification: crystal violet was dissolved in 
0.9% (w/v) sodium chloride solution instead of 0.73% (w/v) sodium chloride 
solution. Crystal violet, 1 g, was added to 50 ml of 0.9% sodium chloride 
solution, shaken five ntinutes and filtered through mirac1oth, lot 901777, 
Calbiochem Corporation, La Jolla, California. The filtrate was ntixed with 
50 ml of 0.9% sodium chloride solution. 
The erythrocytic pipetttl was inserted into the edge of the blood, and the 
blood was allowed to enter to the 0.5 mark on the pipette. The tip of the 
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pipette was immedia tely pl,ce(! in the crystal violet solution until the fluid 
level reached the 1.01 mark. The pipette was shaken vigorously. and the 
erythrocytes were stained for five minutes. 
The cover slip was placed in position over the counting area of a 
hemacytometer. The pipette was shaken again. The tip was placed exactly 
at the junction between the cover slip and the chamber. The diluted blood 
was drawn under the cover slip by capillary action. There were no bubbles 
present under thll cover slip or fluid present in the moats. 
The erythrocytes with and without Heinz bodies were counted in eight of 
the 25 groups of 16 small squares on the hemacytometer. The groups were 
randomly selected. All erythrocytes were counted which touched the upper 
and left boundary lines of the squares but not the cells touching the lower 
and the right boundary lines. The erythrocytes were observed employing a 
Nikon microscope (43X) from Nikon Inc. Instrument Division. Nippon 
Kogaka. KK The method of statistics that employed in this time-course 
study was the t test. 
RESULTS 
Five weeks of data (Figure 2) illustrated that the female subject with a 
splenectomy had the highest ratio of Heinz body-containing erythrocytes to 
r.ormal erythrocytes. In the fourth week, the non-splenectomized female 
Hb Zurich subject had the same ratio as the splenectomized Hb Zurich 
female subject because of menses. The non-splenectomized female and 
male subjects had an intermediate ratio, and the control had the lowe~t 
ratio. Table 1 and Figure 3 contain the mean ratios of the entire five weeks 
and standard deviations. Compared to the mean ratio of the control, the 
ratio ()f the female subject with a splenectomy had the highest significant 
difference. The female and the male subjects had highly significant 
differences as well (Table 2). Since the female subject with a splenectomy 
had th e highest ratio of Heinz body-containing erythrocytes to normal 
erythrocytes and the highest significant difference among the three 
Hemoglobin Zurich subjects, a comparison of the splenectomized subject 
and the non-splenectomized subject was made. The results are also shown 
in Table 2. The ratio of erythrocytes with Heinz bodies of the splenectomized 
female subject and the non-splenectomized female subject still had a 
significant difference. Thus, the splenectomy had an affect on the ratio of 
Heinz body-contai ning erythrocytes to normal erythrocytes. After a 
splenectomy, the ratio increases. In order to determine if the male and the 
female subjects had a different ratio, the Heinz body content of erythrocytes 
from both of the non-splenectomized male and female subjects were 
studied. There was apparently no significant difference Crable 2 ). 
During the five-week study, the non-splt:nectomized Hb Zurich female 
subject was observed to have a monthly jaundice, which was hypothesized 
8 
, 
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to possibly be associated with the menstrual cycle. In the fourth week 
of the study, the non-splenectomized female subject and the control started 
their menses on the same day which coincided with the same day blood 
samples were drawn. Figure 5 shows that both ratios increased. The 
change between the mean ratio of the first three weeks and ratio of the 
fourth week in the non-slJlenectomized Hb Zurich female and the female 
control were almost the same value (Table 3). The data in Table 3 indicate 
that the menstrual cycle had no specific affect on the increased ratio of 
Heinz body-containing erythrocytes to normal erythrocytes in the 
Hemoglobin Zurich subject since the female control had an increased ratio 
during the menstrual cycle as well (Figure 5). 
The male subject's blood sample drawn in the second week which had 
been stored at 4°C, was examined again the fifth week. The ratio of 
erythrocytes with Heinz bodies of stored blood was the same as fresh blood. 
The three females ' blood tha t was drawn and had been stored at 4°C for 4 
months was re-analyzed. All the ratios of the two female subjects and the 
control were much higher than originally recorded. Table 4 and Figure 4 
contain the results of this experiment. 
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TABLE 1 
Mean ratios of Heinz body-containing erythrocytes to normal erythrocytes 
and standard deviations in Hemoglobin Zurich (Hb Zurich) subjects and 
the control during five weeks 
Subjects Mean· Standard deviations 
Splenectomized female 0.19 0.01 
HbZ(S) 
Non-splenectomized 0.14 0.02 
female Hb Z (F) 
Non-splenectomized 0.13 0.01 
male Hb Z (M) 
Non-splenectomized 0.06 0.02 
female control (C) 
*(n=5) 
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TABLE 2 
t values and probability between the Hemoglobin Zurich subjects and the 
control 
Subjects t values Probability 
Splenectomized femRle Hb Zurich vs control (S vs 12.1490 0.001 
C) 
Splenectomized female Hb Zurich vs non- 3.9680 0.020 
splenectomized female Hb Zurich (S vs F) 
Non-splenectomized female Hb Zurich vs control 5.6022 0.010 
(F vs C) 
Non-splenectomized male Hb Zurich vs control 6.7698 0.010 
(M vs C) 
Non-splenectomized female Hb Zurich vs non- 0.8137 0.500 
splenectomized male Hb Zurich (F vs M) 
16 
TABLE 3 
A comparison of the ratio of Heinz body-containing erythrocytes to normal 
erythrocytes between the non-splenectomized Hb Zurich female and the 
female control during their menstrual cycles 
Mean Ratios F* 
First three weeks (average) 0.130 
Fourth week 0.180 
Difference 0.050 
*F: Non-splenectomized Hb Zurich female subject 
**C: Female control 
C** 
0.045 
0.090 
0.045 
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TABLE 4 
The ratio of Heinz body-containing erythrocytes to nonnal erythrocytes of 
fresh and stored blood 
Sample S· F· 
Fresh 0.20 0.12 
Stored 0.29 0.23 
Ratio differences between 0.09 0.11 
fresh and stored samples 
S= Splenectomized female Hemoglobin Zurich (Hb Z) 
F= Non-splenectomized female Hb Z 
M= Non-splenectomized male Hb Z 
C= Non-splenectomized female control 
• Blood was stored four months. 
** Blood was stored two weeks. 
c· MU 
0.04 0.13 
0.11 0.13 
0.07 0 
DISCUSSION 
The results of true study indicate the existence of a significant 
difference in the ratio of Heinz bodies to erythrocytes between the three Hb 
Zurich subjects and the experimental female control. These results indicate 
that Hemoglobin Zurich is less stable than normal hemoglobin since Heinz 
bodies are denatured hemoglobin attached to the inner plasma membrane 
surface. The replacement of the distal rustidine by arginine in Hb Zurich 
leaves a gap at the entrance to the heme pocket so that sulfonamides and 
other steric-related oxidants can bind to the heme-iron pocket [6]. Hb Zurich 
subjects are usually asymptomatic without anemia and severe jaundice 
unless they are administrated oxidative drugs. especially sulfonamides [3]. 
During the five-week period. all the subjects and the control were not taking 
any medication. but Hb Zurich individuals had the higher ratios of Heinz 
body-containing erythrocytes to normal erythrocytes. According to a study 
done by Ernesto et al . [7]. the abnormal beta chains in Hb Zurich have an 
autoxidation rate exceeding those of the normal alpha chains. The 
difference in the rate of autoxidation between beta-normal and beta-
Hemoglobin Zurich is about 25-fold. The alpha chain of both normal 
Hemoglobin and Zurich Hemoglobin have very similar rates of autoxidation 
[8]. Thus. even in the absence of administered sulfonamides. Hb Zurich 
subjects still contain more Heinz bodies in peripheral blood than in the 
control. Another reason may be that the rate of blood filtered by the spleen 
is constant; therefore. the number of Heinz body-containing erythrocytes 
should increase in peripheral blood when splenic filtration is saturated. 
18 
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Also, Heinz body fonnation in cells can be induced by subjecting the cells 
to oxidative stresses. Thece stresses may arise as part of the body's normal 
defense mechanism against infection and disease. Firstly, the body 
temperature could be sufficiently raised to drastically reduce the stability of 
the hemoglo in and cause it to precipitate as Heinz bodies. Secondly, the 
oxidants, such as superoxide and H202 produced by phagocytic cells when 
des troying an infectious agent, could accelerate oxidation and denaturation 
of the unstable hemoglobin [10]. 
Th e r a tio of Heinz body-containing erythrocytes to the normal 
erythrocytes of tI,e splenectomized Hb Zurich subject was statistically 
significant compared to the other non-splenectomized individuals. The 
implication is that splenectomy has an effect on the increased number of 
erythrocytes containing Heinz bodies in peripheral blood. One of the most 
important functions of the spleen is to remove aged or defective blood cells 
and platelets from the blood. This function is lost after a splenectomy. 
Peripheral blood alterations occurring after splenectomy include prompt 
increase in the number of leucocytes, platelets. immature nucleated 
erythrocytes and target cells; a tendency toward t inness of the red cells; 
decreased osmotic fragility; and the appearance of Heinz bodies [l1J. As 
previously described, t he study in which erythrocytes containing denatured 
hemoglobin were injected intravenously in premature infants and patients 
following splenectomy. the rate of Heinz body disappearance was slower in 
splenectomized patients than in control subjects [12J. 
Both of the non-splenectomized male and female Hb Zurich subjects had 
a cyclic jaundice. However, it is clear that the cyclic jaundice is apparently 
not due to the menstrual cycle since it occurs in both the Hb Zurich male 
and the female. The female control, who still undergoes menses, had an 
increased ratio of Heinz body-containing erythrocytes to normal 
erythrocytes during menses as willi. The cyclic jaundice can not be 
explained at the present time. 
In conclusion, Hb Zurich subjects had a higher ratio of Heinz body-
containing erythrocytes, and the splenectomized subject had the highest 
ratio. The menstrual cycle had no effect on the increased ratio of Heinz 
body-containing erythrocytes to normal erythrocytes of Hb Zurich subjects. 
There may be a specific cycle of increased Heinz body-formation m 
peripheral blood for non-splenectomized Hb Zurich subjects. 
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